|
contents | europe | ||||
| Powtech Technopharm in Nuremberg  Living longer, healthier lives has become a global growth market. Behind the capsules and powders marketed under the banner of “longevity” lies sophisticated process engineering. Solutions will be on display at numerous booths at Powtech Technopharm in Nuremberg from September 29 to October 1, 2026. For manufacturers of active pharmaceutical ingredients as well as for machinery and plant engineering companies, this opens a market that is still in the early stages of its industrial maturity.Just a few years ago, “longevity” was a term confined to research labs and California startups. Today, it has become a consumer goods segment experiencing double-digit growth. According to a market study by The Business Research Company, the market for longevity supplements – that is, dietary supplements aimed at healthy aging and cellular function – alone is projected to rise from $8.8 billion in 2025 to $14.3 billion in 2030. If we broaden the market definition to include anti-aging medications, diagnostics, and wellness, forecasts suggest that market volumes will exceed $60 billion over the coming decade. For the process industry, it is not so much the medical hype that is of interest as the question behind it: How are these products actually made? This is where things get exciting for visitors and exhibitors at Powtech Technopharm. Four classes of active ingredients dominate the market. NMN (nicotinamide mononucleotide) is a precursor to the coenzyme NAD⁺, which plays a central role in cellular metabolism. Spermidine, found in wheat germ and soybeans, is considered a driver of the cell’s own “garbage disposal” system. Urolithin A, which is produced in the gut during the breakdown of pomegranate and walnut compounds, is said to trigger the renewal of the cell’s “powerhouses,” the mitochondria. Added to this is the rapidly growing group of senolytics, which are designed to specifically remove old, non-dividing cells from tissue, as well as other NAD⁺ boosters. What these substances have in common from a process engineering perspective is not their biochemistry, but their production logic. All four represent a shift away from an unreliable, microbiome- or plant-dependent “natural” formation toward controlled, reproducible industrial manufacturing of defined quality. And all four ultimately undergo the same basic process engineering operations that constitute the core business of Powtech Technopharm: chemical or biocatalytic reaction, separation and purification, drying into a storage-stable solid, as well as formulation and filling usually as a powder, granule, or capsule. Longevity is not a mature market where processes have long since been optimized, but rather a field in which active ingredient manufacturers and plant engineers are still jointly developing their solutions. Those exhibiting in Nuremberg or wandering through the halls will find here less of a trendy topic and more of a concrete challenge: turning promising biochemistry into reproducible, safe, and affordable products. This is, in the best sense of the word, a process engineering challenge. write your comments about the article :: © 2026 Exhibition News :: home page |